Health care leaders may want to keep a closer eye on clinical validation for artificial intelligence (AI)-enabled medical devices (AIMDs), based on a recent JAMA Health Forum study.
Another key competitor is Graphite, which secured $52 million in funding in March. Graphite benefits from a close partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback